chrisvoncsefalvay/vaers-outcomes huggingface dataset:
SHORTNESS OF BREATH (WORSE UPON EXERTION); ELEVATED HEART RATE; DIZZINESS; CHEST PAIN; WEAKNESS; FEVER; MUSCLE ACHES; HEADACHE; FATIGUE; This spontaneous report received from a patient concerned a 63 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included penicillin allergy, allergy to plavix, and compazine allergy. The patient was previously treated with for drug used for unknown indication; and experienced drug allergy when treated with amlodipine for drug used for unknown indication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A, expiry: UNKNOWN) dose was not reported, administered on 12-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-MAY-2021, the subject experienced shortness of breath (worse upon exertion). On 13-MAY-2021, the subject experienced elevated heart rate. On 13-MAY-2021, the subject experienced dizziness. On 13-MAY-2021, the subject experienced chest pain. On 13-MAY-2021, the subject experienced weakness. On 13-MAY-2021, the subject experienced fever. On 13-MAY-2021, the subject experienced muscle aches. On 13-MAY-2021, the subject experienced headache. On 13-MAY-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, muscle aches, and headache, and had not recovered from shortness of breath (worse upon exertion), elevated heart rate, dizziness, weakness, fatigue, and chest pain. This report was non-serious.
sinus infection; heart palpitations; This spontaneous case was reported by a pharmacist and describes the occurrence of SINUSITIS (sinus infection) and PALPITATIONS (heart palpitations) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, the patient experienced SINUSITIS (sinus infection) and PALPITATIONS (heart palpitations). At the time of the report, SINUSITIS (sinus infection) and PALPITATIONS (heart palpitations) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication history not provided. Treatment information was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: TCR follow up received on June 9th.  Reporter stated that patient never received the vaccine.
Patient started feeling dizzy within 30 seconds after vaccine, shortly after standing up. Before she could be seated again, she fell to floor without losing consciousness. She caught herself with her hands and did not sustain any injuries from the fall. Parent was in the vaccination room at the time of event and both pharmacist and parent sat on floor with patient for several minutes until she felt better. Patient reported feeling hot, dizzy and nauseous. She briefly felt like she needed to vomit, but never did. Once feeling well enough to move had parent remain seated with the child in our waiting area for roughly 30 minutes until all of her symptoms disappeared. Both parent and child felt reaction was due to a panic attack, which she has experience before, but never previously after receiving a vaccination. Called parent later that same day to follow up and make sure child was still feeling ok. Reported child did not experience any additional side effects since leaving pharmacy.
My two infected molars forwich I had been on antibiotics for several days and was in no pain with, began hurting me excruciatingly to the point that I could only eat with my front teeth for the next five days.  I felt like I had swollen glands, migraines of my whole head that came and went, extreme upper torso soreness. My neck muscles were so sore and I was rubbing them all the time.  I was in my pajamas for five days.  On the 6th day I woke up pain free and able to eat anything I wanted.  What a journey.. ihad had no problems with the vaccines.
Legs felt funny; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 57-year-old female patient received BNT162b2 (BNT162B2), on 17Apr2021 as dose 1, single (Batch/Lot number: unknown) at the age of 57 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Rheumatoid arthritis" (ongoing), notes: Rheumatoid arthritis diagnosed 5 year ago. The patient's concomitant medications were not reported. The following information was reported: LIMB DISCOMFORT (non-serious) with onset 18Apr2021, outcome "unknown", described as "Legs felt funny". The event "legs felt funny" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of limb discomfort.  Additional information: There was no family medical history relevant to AE(s) reported. No other products administered. The reporter reported about his wife that she had the first COVID19 vaccine and her leg felt funny. They didn't know the vaccine was causing it. She was seeing a rheumatologist that said never get another COVID vaccine and to report this. The rheumatologist does video conferences with doctors around the country. The rheumatologist said that half of the doctors are saying that they believe it is from the vaccine and the other half are on the fence. The next step is to go for a biopsy because none of the medicines are working. No further details provided. Since first COVID19 vaccine, no other vaccines besides COVID19 vaccine. No additional vaccines administered on same date of the Pfizer suspect. It was hard to read on the card because they wrote it. Reporter can't read the NDC/lot/exp for the first or second doses on the card.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
a reaction in the injection site/ is very itchy; A spontaneous report was received from a consumer/physician concerning a 72 years old, female patient who developed/experienced a reaction in the injection site, very itchy , no rash, no red.  The patient's medical history was not provided.Concomitant product use was not provided/unknown by the reporter.  On 14FEB-2021 ,prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number:[016M20A]  intramuscularly in the  upper left arm for prophylaxis of COVID-19 infection.  On 21-FEB-2021 ,the patient experienced events a reaction in the injection site ,very itchy, no red ,no rash.  Treatment details include hydrochloride and a cortisone cream.  Action taken with mRNA in response to events was not reported.  On an unknown date ,the outcome of events a reaction at the injection site ,very  itchy ,no pain ,no rash was unknown.
Flu like symptoms after first vaccine; Fever 102.5 F after first vaccine; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms after first vaccine) and PYREXIA (Fever 102.5 F after first vaccine) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jul-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms after first vaccine) and PYREXIA (Fever 102.5 F after first vaccine). The patient was treated with CAFFEINE, PARACETAMOL (EXCEDRIN [CAFFEINE;PARACETAMOL]) for Fever, at an unspecified dose and frequency. On 22-Jul-2021, INFLUENZA LIKE ILLNESS (Flu like symptoms after first vaccine) and PYREXIA (Fever 102.5 F after first vaccine) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Jul-2021, Body temperature: 102.5 (High) Body temperature was reported as 102.5 F.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were provided.   This case was linked to MOD-2021-290989 (Patient Link).
Patient almost immediately collapsed, flushed, slight convulsions, supported patent lying down, called 911. patient recovered quickly emt arrived bp was low took patient to er
Arm became red and swollen still on 10/7/11 has dark red 2 cm radius on arm. A red line went down the arm to the elbow. Then small bumps appeared around the site that became crusty.
13 weeks pregnant, healthy.  Rash start evening of vaccine, progressively worsened over the weekend, went to a dermatologist 4 days after vaccine with severe and widespread blisters on chest and back, diagnosed as shingles.
4x4 cm erythema around injection site L leg. Positive tenderness, warmth, edema.
BILATERAL TINGLING AND NUMBNESS OF BOTH HANDS, CHEST TIGHTNESS,  ANXIOUS. CLIENT COMPLAINED THAT SHE WAS GOING IN AND OUT UNCONSCIOUNESS, WAS ALERT AND ORIENTED X 3
Patient reported an red, splotchy rash "a little bit" below the injection site. She stated the rash was hot and sore to the touch.
Patient states she is experiencing a sore arm, and arm hurts when she moves it. She stated her arm is feeling a little bit better today.
Information has been received from a nurse practitioner concerning a female in her "mid teens" who, on an unspecified date, was vaccinated with Gardasil. Concomitant therapy included hepatitis B virus vaccine (unspecified). Subsequently the patient developed a rash all over her body. The patient went to the emergency room but hospitalization is unspecified. Subsequently, the patient recovered from the rash all over her body. Additional information has been requested. The product quality complaint unit was not involved.
BOOSTRIX was given instead of KINRIX. Manufacturer was contacted. No adverse reaction or problem. Pt mom was called and informed. Asked to bring child in for the polio vaccine which was not in BOOSTRIX.
Swelling, erythema, tenderness of L. deltoid 3 days after vaccine admin.
She was set to be discharged on September 18, 2012; however, after having received her Pneumovax vaccine, she began to feel dizzy and subsequently was noted to lose consciousness. She was standing at the time, fell back into her chair, was helped into bed and noted to be mildly tachycardic in atrial fibrillation with a rate in the low 100s with a stable blood pressure. She came to on her own after approximately 1 minute time, was noted to be diaphoretic. EKG done at the time revealed no ischemic changes, but did have at new incomplete right bundle branch block. She was monitored overnight on telemetry with no further events. She had 3 sets of cardiac enzymes cycled, which were negative. Orthostatic vital signs were checked and negative. Repeat EKG in the morning revealed resolution of her right bundle branch block. This was discussed briefly with Cardiology and felt to not be the cause of her event. She was hydrated overnight as well for any possible orthostasis that may have contributed to the episode, given that she was standing; however, it was felt to likely be a vasovagal event from vaccine administration given her symptoms.
Severe migraine, body aches, loss of sleep, strong pain in shoulder of injection site.
Fever. Blood spots. Cough. Fatigue . Irritability. Runny nose
When vaccination provider was administering the vaccine some of the liquid leaked out.; No adverse event; Patient received his 6th Moderna shot on 23-APR-2023, but when vaccination provider was administering the vaccine some of the liquid leaked out.; This spontaneous case was reported by a patient and describes the occurrence of UNDERDOSE (Patient received his 6th Moderna shot on 23-APR-2023, but when vaccination provider was administering the vaccine some of the liquid leaked out.), DEVICE CONNECTION ISSUE (When vaccination provider was administering the vaccine some of the liquid leaked out.) and NO ADVERSE EVENT (No adverse event) in an elderly male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     It was unknown if patient had any relevant medical history, allergy, concomitant diseases, risk factor and unknown if received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On 23-Apr-2023, the patient received sixth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 23-Apr-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced UNDERDOSE (Patient received his 6th Moderna shot on 23-APR-2023, but when vaccination provider was administering the vaccine some of the liquid leaked out.). On an unknown date, the patient experienced DEVICE CONNECTION ISSUE (When vaccination provider was administering the vaccine some of the liquid leaked out.) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (Patient received his 6th Moderna shot on 23-APR-2023, but when vaccination provider was administering the vaccine some of the liquid leaked out.), DEVICE CONNECTION ISSUE (When vaccination provider was administering the vaccine some of the liquid leaked out.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for UNDERDOSE (Patient received his 6th Moderna shot on 23-APR-2023, but when vaccination provider was administering the vaccine some of the liquid leaked out.) and DEVICE CONNECTION ISSUE (When vaccination provider was administering the vaccine some of the liquid leaked out.).    No concomitant information was reported. It was reported that patient had no adverse events with previous vaccines or the last one so far. Suspect product dosage text was reported as additional booster. No treatment information was provided.   Reporter did not allow further contact
Information has been received from a Licensed Practical Nurse referring to multiple patients of unknown age and gender. The patients' medical history, concurrent condition and concomitant therapy were not provided. On unknown dates, the patients were vaccinated with doses of improperly stored GARDASIL 9 (lot# M004116, expiration date 12-OCT-2017, dose and route were not reported). There was no previous temperature excursion. Digital data logger involved. The vaccine had been stored under the lowest temperature of 0.8 Celsius degree for cumulative 2 hours and 41 minutes. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Syncope the early morning following vaccination with head laceration, resulting in emergency room visit, work up and suturing of laceration. Patient had accompanying fever and chills morning following vaccination. Negative head CT and lab work up, felt to be consistent with vasovagal syncope.
second dose: day 1-4 nauseas, day 5 to date severe headache at all times, diarrhea, day 9 to date. Treatment: 4 September: TORADOL, September 5: Panadol, TORADOL, ADVIL, September 8: Gabapentin, Lactobacillus, PEPTIDE, SOLUMEDROL. Symptoms still remain the same.
G2P1, EDD: 03/17/2016, 7lbs 2oz male, Pt c/o vertigo and nausea the night before. She did not feel well and went to bed at 7:30pm. At 6:30am, pt started leaking amniotic fluid, called our office for an appt which confirmed ROM and emergency repeat C-section was scheduled for that day.
Myalgia, Arthralgia, Fever, CHILLS, FATIGUE Narrative:  Other Relevant History:
Patient had swelling, pain and redness in injection arm.  Patient also had low grade fever.
Lump appeared in the collar bone/a lump appeared in the clavicle in the same side where the vaccine; Swollen lymph/ May be a swollen gland; Achy; A spontaneous report was received from a healthcare professional concerning a 64-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events lump appeared in the collar bone, lump appeared in the clavicle in the same side where the vaccine was administered, swollen gland, swollen lymph/ Lymphadenopathy and achy/Myalgia.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 9 Jan 2021, prior to the onset of the events the patient received second of two planned doses of mRNA-1273 (lot/batch: 030420A) via unknown route in the left arm for prophylaxis of COVID-19 infection.  On 6 Feb 2021, after receiving the second dose, the patient experienced a lump appeared in the clavicle in the same side where the vaccine was administered, swollen lymph, it may be a swollen gland and achy. The patient informed that lump was getting smaller. The patient treated the events with Ibuprofen .  Action taken with mRNA-1273 in response to the events was unknown.   The outcome of event for the event lump appeared in the collar bone was resolving.  The outcome of event for the event swollen lymph, it may be a swollen gland and achy was unknown.
Rashes after 3 months of receiving second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rashes after 3 months of receiving second dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In June 2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (Rashes after 3 months of receiving second dose). At the time of the report, RASH (Rashes after 3 months of receiving second dose) outcome was unknown.            Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.
Sx begin 27MAR91 joint pain in lt knee w/swelling to rt knee then to both ankles; sx stopped w/in 24hrs; On 29MAR91 fingers & both hands began to swell; By today pt has difficulty writing & has tingling in both hands w/swelling;
Started with severe posterior thigh pain and cramping. Pair became progressively worse and she was unable to walk. Hospital ER, Admission, Rehab. Treatment with high dose steroids. Diagnosed with Transverse Myelitis at the L2 level. Remains wheel chair bound at this time. 5/5/06 Medical records received from 1st hospital which reveal patient received flu vaccine approx 1 mo prior to experiencing sudden onset severe posterior thigh pain w/cramping on 12/11/05 which became progressively worse & she presented to the ER.  MRI of the LS spine showed edema of terminal spinal cord & clonus.  Patient was then transferred to larger hospital for evaluation which revealed diagnosis of acute transverse myelitis at L2 level.  She was treated with high dose steroids w/ on ly approx 30-40% improvement in symptoms & was transferred back to initial treating facility.  Has continued pareparesis & weakness of the quadriceps femoris & illiopsoas muscles in the distribution of the posterior tibial & common peroneal nerves consistent w/L2 transverse myelitis, worse on the right, along w/bowel & bladder incontinence.  PMH: MVP & HTN.  5/11/06 Received medical records from PCP which reveal patient had shingles 4/05.  As of 3/06, patient only able to take a few steps w/a walker.  5/30/06 Received medical records from larger hospital which did not reveal any new dx/ss
High fever as high as 102.4, dizzy, nausea, aches all over, weak, headache, stomach ache, shaking chills.
The patient has developed an acute deep venous thrombosis in the right popliteal and trifurcation vessels of the calf. She has an elevated d-dimer of 14,738  and acute hypoxic respiratory failure due to pulmonary embolism.
1st Vaccine, Soreness in Arm, Fatigue, Insomnia and welt on injection site with redness and itchiness lasted for 10 years, Menstruation cycle was sever - increased in mirgraine, fatigue, and bleeding 2nd Vaccine - Fatigue, Insonmia, Fever, Flu like symptoms, breakthrough bleeding in between mentruation cycles. Injectiong site size of a baseball including rediness and soreness
Right arm swollen, rash on arm down to elbow, rash on inner left knee identical to elbow, headache.
This spontaneous report as received from a medical assistant refers to a patient of an unknown age and gender. No information regarding the patients' medical history, concurrent conditions and concomitant medications was provided. On 13-JUN-2016, the patient received dose of improperly stored VAQTA with lot# M011116 and expiration date 17-MAY-2017, via intramuscular route (dose was not reported). Administered dose underwent temperature excursions at 31 Fahrenheit degrees, for 10 hours. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information is not expected.
This spontaneous report was received from a registered nurse, via company representative, refers to a patient of unknown age and gender. The patient was vaccinated with the first, the second and the third dose of GARDASIL (dose, route and lot number were not reported), on 13-JUN-2007, 01-NOV-2007, and 17-DEC-2007, respectively. The reporter stated that the patient was vaccinated with first two doses of the GARDASIL on time but then was administered the third dose in the GARDASIL series six weeks after the second dose (on 17_DEC-2007). No known adverse effect reported. Additional information has been requested.
Patient had a stroke, left leg felt heavy, started having breathing problems, and you entire left side went numb and weak. Patient went to the hospital, referred to Medical Center
The first 24 hours after receiving the 2nd dose I couldn?t move my left arm at all.Eventually it got better but I would get pressure pain on the left arm and at the exact spot where the vaccine was given.Days later I started feeling upper back pain,followed by chest pain,vertigo,clogged ears,swelling around the neck and behind ears.
VERY SORE LEFT ARM. HEAD ACHE,WEAKNESS ,TIRED, VOMIT AND DIARRHEA,NO APPETITE AND FEVER STILL NOT 100% FEELING WISE ARE NOT SORE NO MORE VOMIT AND DIARRHEA  OR FEVER STILL FELL WEAKISH.
Patient experienced rash, hive and irritation on the body, and he said that he is not using anything
Axillary and supraclavicular lymphadenopathy and soreness on ipsilateral side of injection
Pt. received Covid #1 at 8:20 a.m. , 10 minutes later, she experienced palpitations along with heart rate of 90-100. Other vital signs stable. O2 sat 100% , afebrile.  This went on for 1 1/2 hours on and off of wellness then again with the episode.  She also experienced diarrhea X2 within the 1  1/2 hour span.  This  adverse event seems to be a vasovagal reaction to the injection and not to the vaccine itself.
This is a spontaneous report from a contactable physician via Pfizer sales representative. This physician reported similar events for 5 patients. This is 5th of five reports. A patient of unspecified age ethnicity and gender received TRUMENBA, via an unspecified route of administration on an unspecified date at single dose for immunisation. The patient medical history and concomitant medications were not reported. The patient experienced high fever on an unspecified date with outcome of unknown. Sender's Comments: Linked Report(s) : US-PFIZER INC-2016580735 as same reporter/drug/event, different patient.